The effect of recipient cytokine gene polymorphism on cardiac transplantation outcome

Human Immunology

Volumn 65, Issue 3, 2004, Pages 248-254

  Gourley, Ian S ^a   Denofrio, David ^b   Rand, William ^c   Desai, Shashank ^a   Loh, Evan ^a   Kamoun, Malek ^a,d  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Acute rejection; Allograft vasculopathy; Cytokine; Gene polymorphism; Heart transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLOGRAFT; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; DNA POLYMORPHISM; FEMALE; GENOTYPE; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MYCOSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; POPULATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STEROID THERAPY; VASCULAR DISEASE; VIRUS INFECTION;

ADULT; DNA PRIMERS; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFECTION; INTERFERON TYPE II; INTERLEUKINS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1642399709     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2004.01.008     Document Type: Article

References (31)

1. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A. 94:1997;3195.
2. Awad M.R., El-Gamel A., Hasleton P., Turner D.M., Sinnott P.J., Hutchinson I.V. Genotypic variation in the transforming growth factor-β1 gene: association with transforming growth factor-beta 1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation. 66:1998;1014.
3. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 24:1997;1.
4. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 102:1998;1369.
5. Perrey C., Pravica V., Sinnott P.J., Hutchinson I.V. Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta 1 and tumour necrosis factor-a genes: a technical report. Transpl Immunol. 6:1998;193.
6. Pravica V., Asderakis A., Perrey C., Hajeer A., Sinnott P.J., Hutchinson I.V. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet. 26:1999;1.
7. Pravica V., Perrey C., Stevens A., Lee J.-H., Hutchinson I.V. A single nucleotide polymorphism in the first intron of the human IFN-γ gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-γ production. Hum Immunol. 61:2000;863.
8. Warlé M.C., Farhan A., Metselaar H.J., Hop W.C.J., Perrey C., Zondervan P.E., Kap M., Kwekkeboom J., Ijzermans J.N.M., Tilanus H.W., Pravica V., Hutchinson I.V., Bouma G.J. Are cytokine gene polymorphisms related to in vitro cytokine production profiles? Liver Transpl. 9:2003;170.
9. Lin M.-T., Storer B., Martin P.J., Tseng L.-H., Gooley T., Chen P.-J., Hansen J.A. Relation of an interleukin-10 promoter polymorphism to graft survival after hematopoietic-cell transplantation. N Engl J Med. 349:2003;2201.
10. Hajeer A.H., Hutchinson I.V. TNF-a gene polymorphism: clinical and biological implications. Microsc Res Tech. 50:2000;216.
11. Knight J.C., Kwiatkowski D. Inherited variability of tumor necrosis factor production and susceptibility to infectious disease. Proc Assoc Am Physicians. 111:1999;290.
12. Sullivan K.E., Wooten C., Schmeckpeper B.J., Goldman D., Petri M.A. A promoter polymorphism of tumor necrosis factor a associated with systemic lupus erythematosus in African-Americans. Arthritis Rheum. 40:1997;2207.
13. Rood M.J., van Krugten M.V., Zanelli E., van der Linden M.W., Keijsers V., Schreuder G.M.T., Verduyn W., Westendorp R.G., de Vries R.R., Breedveld F.C., Verweij C.L. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum. 43:2000;129.
14. Holweg C.T., Baan C.C., Balk A.H., Niesters H.G., Maat A.P., Mulder P.M., Weimar W. The transforming growth factor-beta 1 codon 10 gene polymorphism and accelerated graft vascular disease after clinical heart transplantation. Transplantation. 71:2001;1463.
15. Bathgate A.J., Pravica V., Perrey C., Therapondos G., Plevris J.N., Hayes P.C., Hutchinson I.V. The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection. Transplantation. 69:2000;1514.
16. Densem C.G., Hutchinson I.V., Cooper A., Yonan N., Brooks N.H. Polymorphism of the transforming growth factor-beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation. J Heart Lung Transplant. 19:2000;551.
17. Azzawi M., Hasleton P.S., Turner D.M., Yonan N., Deiraniya A.K., Sinnott P.J., Hutchinson I.V. Tumor necrosis factor-a gene polymorphism and death due to acute cellular rejection in a subgroup of heart transplant recipients. Hum Immunol. 62:2001;140.
18. Poli F., Boschiero L., Giannoni F., Tonini M., Scalamogna M., Ancona G., Sirchia G. Tumour necrosis factor-a gene polymorphism: implications in kidney transplantation. Cytokine. 12:2000;1778.
19. Foster C.B., Lehrnbecher T., Samuels S., Stein S., Mol F., Metcalf J.A., Wyvill K., Steinberg S.M., Kovacs J., Blauvelt A., Yarchoan R., Chanock S.J. An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus. Blood. 96:2000;2562.
20. Jahromi M., Millward A., Demaine A. A CA repeat polymorphism of the IFN-gamma gene is associated with susceptibility to type 1 diabetes. J Interferon Cytokine Res. 20:2000;187.
21. Jahromi M.M., Millward B.A., Demaine A.G. A polymorphism in the promoter region of the gene for interleukin-6 is associated with susceptibility to type 1 diabetes mellitus. J Interferon Cytokine Res. 20:2000;885.
22. Khani-Hanjani A., Lacaille D., Hoar D., Chalmers A., Horsman D., Anderson M., Balshaw R., Keown P.A. Association between dinucleotide repeat in non-coding region of interferon-gamma gene and susceptibility to, and severity of, rheumatoid arthritis. Lancet. 356:2000;820.
23. Li B., Khanna A., Sharma V., Singh T., Suthanthiran M., August P. TGF-beta1 DNA polymorphisms, protein levels, and blood pressure. Hypertension. 33:1999;271.
24. McGuire W., Hill A.V., Allsopp C.E., Greenwood B.M., Kwiatkowski D. Variation in the TNF-a promoter region associated with susceptibility to cerebral malaria. Nature. 371:1994;508.
25. Roy S., McGuire W., Mascie-Taylor C.G.N., Saha B., Hazra S.K., Hill A.V.S., Kwiatkowski D. Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. J Infect Dis. 176:1997;530.
26. Turner D., Grant S.C.D., Yonan N., Sheldon S., Dyer P.A., Sinnott P.J., Hutchinson I.V. Cytokine gene polymorphism and heart transplant rejection. Transplantation. 64:1997;776.
27. Freeman R.B. Jr, Tran C.L., Mattoli J., Patel K., Supran S., Basile F.G., Krishnamurthy S., Aihara R. Tumor necrosis factor genetic polymorphisms correlate with infections after liver transplantation. NEMC TNF Study Group. New England Medical Center Tumor Necrosis Factor. Transplantation. 67:1999;1005.
28. Sahoo S., Kang S., Supran S., Saloman R., Wolfe H., Freeman R.B. Tumor necrosis factor genetic polymorphisms correlate with infections after renal transplantation. Transplantation. 69:2000;880.
29. Awad M.R., Webber S., Boyle G., Sturchioc C., Ahmed M., Martell J., Law Y., Miller S.A., Bowman P., Gribar S., Pigula F., Mazariegos G., Griffith B.P., Zeevi A. The effect of cytokine gene polymorphisms on pediatric heart allograft outcome. J Heart Lung Transplant. 20:2001;625.
30. Marshall S.E., McLaren A.J., Haldar N.A., Bunce M., Morris P.J., Welsh K.I. The impact of recipient cytokine genotype on acute rejection after renal transplantation. Transplantation. 70:2000;1485.
31. Akalin E., Murphy B. Gene polymorphisms and transplantation. Current Opin Immunol. 13:2001;572.